Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.

Shrewsberry AB, Osunkoya AO, Jiang K, Westby R, Canter D, Pattaras J, Turgeon N, Master VA, Ogan K.

Clin Transplant. 2014 Feb;28(2):211-6. doi: 10.1111/ctr.12299.

PMID:
24494735
2.

Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.

Breda A, Lucarelli G, Rodriguez-Faba O, Guirado L, Facundo C, Bettocchi C, Gesualdo L, Castellano G, Grandaliano G, Battaglia M, Palou J, Ditonno P, Villavicencio H.

World J Urol. 2015 Jan;33(1):1-7. doi: 10.1007/s00345-014-1248-y. Epub 2014 Feb 7. Erratum in: World J Urol. 2015 Jan;33(1):9. Luccarelli, Giuseppe [corrected to Lucarelli, Giuseppe].

PMID:
24504760
3.

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ; Comité de Transplantation de l'Association Française d'Urologie; Comité de Cancérologie de l'Association Française d'Urologie.

Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2.

PMID:
21377780
4.

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L; members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU); Comité de Transplantation de l'Association Française d'Urologie (CTAFU).

BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.

5.

[The clinicopathological characteristics in renal cell carcinoma with end-stage renal disease].

Maru N, Iwamura M, Ishii J, Minei S, Saito T, Yoshida K, Baba S.

Nihon Hinyokika Gakkai Zasshi. 2003 Mar;94(3):434-8. Japanese.

6.

Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.

Chen K, Huang HH, Aydin H, Tan YH, Lau WK, Cheng CW, Yuen JS.

Scand J Urol. 2015 Jun;49(3):200-4. doi: 10.3109/21681805.2015.1019561. Epub 2015 Mar 17.

PMID:
25783025
7.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
8.

Renal cell carcinoma and end stage renal disease.

Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler SA, Fowler JE Jr.

J Urol. 2006 Jun;175(6):2018-20; discussion 2021.

PMID:
16697788
9.

Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.

10.

Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.

Schmitges J, Trinh QD, Sun M, Hansen J, Bianchi M, Jeldres C, Perrotte P, Dahlem R, Shariat SF, Chun FK, Montorsi F, Menon M, Fisch M, Graefen M, Karakiewicz PI.

BJU Int. 2012 Sep;110(6 Pt B):E183-90. doi: 10.1111/j.1464-410X.2012.10936.x. Epub 2012 Feb 9.

11.

Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.

Shindo T, Masumori N, Kobayashi K, Fukuta F, Hirobe M, Tonooka A, Hasegawa T, Kitamura H, Tsukamoto T.

BJU Int. 2013 May;111(6):941-5. doi: 10.1111/j.1464-410X.2012.11771.x. Epub 2013 Jan 25.

12.

Functional and oncological outcomes of partial nephrectomy of solitary kidneys.

La Rochelle J, Shuch B, Riggs S, Liang LJ, Saadat A, Kabbinavar F, Pantuck A, Belldegrun A.

J Urol. 2009 May;181(5):2037-42; discussion 2043. doi: 10.1016/j.juro.2009.01.024. Epub 2009 Mar 18.

PMID:
19298974
13.

Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.

Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB, Cosimi AB, Tolkoff-Rubin N.

Kidney Int. 2002 Jun;61(6):2201-9.

14.

Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.

Hashimoto Y, Takagi T, Kondo T, Iizuka J, Kobayashi H, Omae K, Yoshida K, Tanabe K.

Int J Clin Oncol. 2015 Oct;20(5):1035-41. doi: 10.1007/s10147-015-0812-9. Epub 2015 Mar 12.

PMID:
25762166
15.

Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.

Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M, Montironi R, Tamboli P, Monzon F, Amin MB.

Am J Surg Pathol. 2015 Jul;39(7):873-88. doi: 10.1097/PAS.0000000000000446.

PMID:
25970682
17.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
18.

Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.

Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H.

Urology. 2003 Oct;62(4):641-6. Review.

PMID:
14550434
19.

Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.

Klatte T, Seitz C, Waldert M, de Martino M, Kikic Z, Böhmig GA, Haitel A, Schmidbauer J, Marberger M, Remzi M.

BJU Int. 2010 May;105(9):1260-5. doi: 10.1111/j.1464-410X.2009.08941.x. Epub 2009 Oct 10.

20.

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project.

Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22.

PMID:
22748912

Supplemental Content

Support Center